Wave Life Sciences Ltd — Cash Flow (NASDAQ:WVE) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities -115.98 M-88.99 M-127.78 M-19.43 M-151.03 M187.49 M -119.94 M Cash from investing activities -1.34 M-560 K-1.25 M-1.11 M-938 K718 K 222 K Cash from financing activities 154.54 M55.83 M67.19 M132.53 M253.89 M488.24 M 488.24 M Free cash flow -117.32 M-89.55 M-129.14 M-20.55 M-151.96 M186.78 M -120.66 M

新闻

Wave Life Sciences (WVE) Reports Q4 Loss, Tops Revenue Estimates

Wave Life Sciences Q4 每股收益逊于预期, 营收超出预期

Wave Life Sciences财报在即投资者聚焦肥胖症押注

Wave Life Sciences: WVE-006 Now In Focus, Navigating Opportunity And Risk (NASDAQ:WVE)

国联民生证券：小核酸重构减肥逻辑 INHBE与ALK7靶点初步验证

Canaccord上调WAVE Life Sciences目标价至43美元，此前为40美元

WAVE Life Sciences stock price target raised to $43 from $40 at Canaccord

H.C. Wainwright重申WAVE Life Sciences评级为"买入"

WAVE Life Sciences stock rating reiterated at Buy by H.C. Wainwright

雷蒙德詹姆斯重申WAVE Life Sciences股票评级，因其重获药物权利

WAVE Life Sciences stock rating reiterated by Raymond James on regained drug rights

Clear Street上调WAVE Life Sciences股票目标价至50美元，看好AATD项目